-
-
Nearly a week after pulling Relyvrio, Amylyx to engage regulators about the drug’s path in another rare disease
-
Mural debuts preclinical data for potential cytokine therapy pipeline additions
To bring CAR-T to solid tumors, Poseida thinks we need to boost conditioning therapy
For Chinese biotechs, the out-licensing business is scorching hot. Could geopolitics rain on their parade?
Philips plots return to US sleep apnea market after final consent decree in CPAP recall
In The News
- Economic Storm Clouds Hovering Over Trump and Global Leaders August 25, 2019 By News Team
- UN: Possible to Eradicate Malaria, but Probably Not Soon August 24, 2019 By News Team
- Climate Change Turns Arctic Into Strategic, Economic Hotspot August 23, 2019 By News Team
Biotechnology Today
more-
Verastem, Quanta and Frontier demonstrate KRAS inhibitors’ potential in preclinical data
Verastem Oncology, Frontier Medicines, Quanta Therapeutics and more shared preclinical updates at the American Association…
Nearly a week after pulling Relyvrio, Amylyx to engage regulators about the drug’s path in another rare disease
Mural debuts preclinical data for potential cytokine therapy pipeline additions
To bring CAR-T to solid tumors, Poseida thinks we need to boost conditioning therapy
Synthekine hopes new IL-2 will be the high-alpha in a beta class
Markets
more-
Weekly Market Review – July 20, 2024
Stock Markets The major stock market indexes ended mixed for the week. The 30-stock Dow…
Bio Space
moreFor Chinese biotechs, the out-licensing business is scorching hot. Could geopolitics rain on their parade?
Athena Countouriotis, M.D., is no procrastinator—the CEO of Avenzo Therapeutics…
Philips plots return to US sleep apnea market after final consent decree in CPAP recall
A U.S. federal court has officially ordered Philips to restrict…
Vertex pays $4.9 billion to hike Alpine’s immunology trail
Vertex Pharmaceuticals is buying Alpine Immune Sciences for $4.9 billion,…
Global News
moreSpaceX Starlink wins permit to send internet to customers like you
SpaceX has been busy building its Starlink satellite constellation. To…
Facebook video calls soar 1000% during Italy’s lockdown
Facebook has seen usage across its platforms surge in countries…
WeWork board’s special committee is demanding that SoftBank follow through with investment
Five months after SoftBank agreed to a massive bailout of…
Verastem, Quanta and Frontier demonstrate KRAS inhibitors’ potential in preclinical data
Nearly a week after pulling Relyvrio, Amylyx to engage regulators about the drug’s path in another rare disease
Mural debuts preclinical data for potential cytokine therapy pipeline additions
To bring CAR-T to solid tumors, Poseida thinks we need to boost conditioning therapy
For Chinese biotechs, the out-licensing business is scorching hot. Could geopolitics rain on their parade?
Philips plots return to US sleep apnea market after final consent decree in CPAP recall
Vertex pays $4.9 billion to hike Alpine’s immunology trail
J&J offers Rallybio $7M in info swap for trials of maternal-fetal disease
Synthekine hopes new IL-2 will be the high-alpha in a beta class
Cancer vaccines get a reintroduction as readouts support ‘path forward’ for the tech